Japan Telemedicine Market Analysis Report 2022 to 2030

Japan Telemedicine Market Analysis

$ 3999

Japan's Telemedicine Market is projected to grow from $3.779 Bn in 2022 to $14.894 Bn by 2030, registering a CAGR of 18.70% during the forecast period of 2022-2030. Japan has one of the oldest populations in the world, which has led to a higher demand for healthcare services. Telemedicine offers a way to provide healthcare to elderly patients who may have difficulty traveling to a hospital or clinic. Some key players in the Japanese telemedicine market include NTT Data, NEC Corporation, Fujitsu Limited, Panasonic Corporation, and Toshiba Corporation. Other notable players include telemedicine companies such as M3 Inc, Sony Corporation, Hitachi, Ltd, and Olympus Corporation.

ID: IN10JPDH010 CATEGORY: Digital Health GEOGRAPHY: Japan AUTHOR: Shivam Zalke

Buy Now

Japan Telemedicine Market Executive Summary

Japan's Telemedicine Market is projected to grow from $3.779 Bn in 2022 to $14.894 Bn by 2030, registering a CAGR of 18.70% during the forecast period of 2022-30.

As Japan's population ages quickly, it is decreasing. By 2060, the population may drop from 127 Mn to 87 Mn, a reduction of up to one-third. By 2060, there will be 40% more people over 65 than there are currently (27%). The ageing and shrinking population of Japan will affect demand and possibilities across the whole economy, despite efforts by the Japanese government and business sector to counteract the consequences of this demographic loss on economic growth and government budget resources.

The nominal and PPP GDPs of Japan are $5.4 and $5.6 Tn, respectively, in 2022. Japan's GDP position is third (nominal) and fourth (PPP) in 2022, demonstrating that it has a strong global economy. Additionally, Japan's GDP per capita ranks 43rd (PPP) and 31st (nominal) in 2022. Being the most developed economy, its inflation rate is also unacceptably low. The lowest inflation rate among developed nations is expected to be achieved by Japan in 2020 when it will be -0.2%.

The telemedicine market in Japan is expected to grow significantly in the coming years due to the government's efforts to promote the use of telemedicine, the aging population, and the shortage of healthcare professionals. The market is also expected to benefit from technological advancements, such as 5G and AI, which are making it possible to provide more advanced telemedicine services.

The market is segmented into hardware, software, and services. The software segment is expected to be the largest segment of the market in the future due to the increasing demand for telemedicine solutions and the growing adoption of electronic health records (EHRs).

The telemedicine market in Japan is also divided into various end-users such as hospitals and clinics, home healthcare, and remote patient monitoring. Hospitals and clinics are expected to be the largest end-users of telemedicine services, as they are the primary providers of healthcare services in Japan.

The major companies operating in the Japanese telemedicine market include NTT Data, NEC Corporation, Fujitsu Limited, Panasonic Corporation, Toshiba Corporation, M3 Inc, Sony Corporation, Hitachi, Ltd, Olympus Corporation, and others.

Overall, the telemedicine market in Japan is expected to grow at a significant rate during the forecast period due to the growing need for remote healthcare services, the aging population, and the increasing acceptance of telemedicine.

Japan telemedicine market analysis

Market Dynamics

Market Growth Drivers

The key factors driving the market growth include the increasing prevalence of chronic conditions, aging population, telehealth uptake, and rising demand for reduction in care costs. The social shift to overall mental well-being and rising healthcare consumerism are other key factors anticipated to propel market growth.

Market Growth Restraints

Healthcare fraud is an important consideration in the area of telehealth and telemedicine practices. There are numerous ways a patient or a physician can be victimized.

Competitive Landscape

Key Players

Some of the major players operating in the Japan Telemedicine market:

Micin (JPN)
Medley (JPN)
MRT (JPN)
Philips
Boehringer Ingelheim
ROMVAC COMPANY S.A.
Hester Biosciences Limited
Indovax
Eli Lilly and Company
Ceva
Zoetis
Venkys India
Phibro animal health corporation
Merk & Co., Inc.
Bayer AG
Merial Animal Health (Sanofi)
AffiniTech, Ltd
Bimeda, Inc.

Healthcare Policies and Regulatory Landscape

Japan’s Ministry of Health, Labor, and Welfare (MHLW) is the regulatory body that oversees food and drugs in Japan, which includes creating and implementing safety standards for medical devices and drugs. The Pharmaceutical and Medical Device Agency (PMDA), a separate organization that works with the MHLW, is in charge of examining applications for drugs and medical devices. In order to evaluate the safety of new products, create thorough rules, and keep track of post-market safety, the PMDA collaborates with the MHLW.

In Japan, there are numerous complex regulatory issues and difficulties related to telehealth services. According to Article 17 of the Medical Practitioners Act of Japan, only certified and authorized physicians are allowed to engage in "medical practice." Therefore, a non-physician telehealth service provider must be sure that their offering does not amount to "medical practice."

1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Telemedicine Market Segmentation

Component

Product
- Hardware
- Software
- Others
Services
- Tele-consulting
- Tele-monitoring
- Tele-education

Modality

The industry is driven by three concepts, which include real-time (synchronous), store and forward (asynchronous), and others comprising remote patient monitoring, etc.

Store and forward
Real-time
Others

Application

Teleradiology
Telepsychiatry
Telepathology
Teledermatology
Telecardiology
Others

Delivery Mode

Web/Mobile
Audio/Text-based
Visualized
Call centers

Facility

Tele-hospital
Tele-home

End-user

Providers
Payers
Patients
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.